The table below shows Crinetics Pharmaceuticals, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
-
$1.04M
$4.01M
$4.74M
$1.08M
$71.00K
Cost of revenue
$1.08M
$0.00
$0.00
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$332.06M
$240.16M
$168.53M
$130.22M
$84.25M
$57.00M
SG&A
CRNX annual revenue (10-K history)
Crinetics Pharmaceuticals, Inc. reported annual revenue of $7.70M for fiscal year 2025. That is up 640.7% from $1.04M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $589.00K (FY 2016) to $7.70M. Figures come from the company's audited annual reports as filed with the SEC.